1)  14-3-3 τ protein
					
	
					
				
				
	
					
				14-3-3τ蛋白
				1.
					Objective To investigate the effects of 14-3-3 τ protein secreted by human trophoblast cells on the expression of integrin αvβ3 protein in human endometrial stromal cells.
						
						目的探讨滋养细胞分泌14-3-3τ蛋白对子宫内膜基质细胞容受性分子整合素αvβ3表达的影响。
					
					2)  14-3-3 protein
					
	
					
				
				
	
					
				14-3-3蛋白
				1.
					Diagnostic value of quantitative test of 14-3-3 protein in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease;
						
						脑脊液14-3-3蛋白定量检测对散发性Creutzfeldt-Jakob病的诊断价值
					2.
					Overexpression of 14-3-3 protein protects pheochromocytoma cells against 1-methyl-4-phenylpyridinium toxicity;
						
						14-3-3蛋白过表达减轻1-甲基-4-苯基吡啶离子对PC12细胞的毒性(英文)
					3.
					Cloning and analysis of 14-3-3 protein cDNA fragment of Dunaliella salina;
					
					
						
						
					
						杜氏盐藻14-3-3蛋白cDNA片段的克隆与分析
					
					3)  14-3-3β protein
					
	
					
				
				
	
					
				14-3-3β蛋白
				1.
					14-3-3β protein is high expressed in tissue of Kaposi s Sarcoma and may correlate with development and prognosis of Kaposi s Sarcoma closely.
						
						其中14-3-3β蛋白在卡波肉瘤组织中高表达,与其发生、发展相关。
					
					4)  14-3-3sigma protein
					
	
					
				
				
	
					
				14-3-3σ蛋白
				1.
					Advances on 14-3-3sigma protein in human malignant tumors;
					
					
						
						
					
						14-3-3σ蛋白在人类恶性肿瘤中的研究进展
					
					5)  14-3-3ηprotein
					
	
					
				
				
	
					
				14-3-3η蛋白
				1.
					Some studies reported that 14-3-3ηprotein could bind to 199-serine phosphorylated p33~(ING1b),hinder its nuclear transportation, and retain it in the cytoplasm of HeLa cells, where it lost its ability of tumor suppressing.
						
						有报导在HeLa细胞中,14-3-3η蛋白可与199位丝氨酸磷酸化的p33~(ING1b)结合,结合后阻止后者的入核转运,将其滞留于胞浆,使其抑瘤作用消失;亦有报导通过联合转染外源性p53与p33~(ING1b)基因,使二者在恶性胶质瘤细胞中共表达可增加后者入核转运效率,但在恶性胶质瘤细胞中p33~(ING1b)胞浆蓄积的确切机制尚待进一步研究证实。
					
					6)  14-3-3δprotein
					
	
					
				
				
	
					
				14-3-3δ蛋白
				1.
					ObjectiveTo investigate the expression of CDC25B,14-3-3δprotein and theirs correlation with pathological grade,clinical stage in bladder carcinoma.
						
						目的探讨CDC25B和14-3-3δ蛋白在膀胱癌中的表达与病理分级、临床分期的关系。
					补充资料:[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
		分子式:C16H16ClN3O3S
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
		
		分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
	参考词条